| Larry L Mattingly, DO | |
|
2233 Park Avenue, Ste 303, Orange Park, FL 32073 | |
| (904) 264-6800 | |
| (904) 264-7066 |
| Full Name | Larry L Mattingly |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 2233 Park Avenue, Orange Park, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194732255 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | OS5284 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Larry L Mattingly, DO 2233 Park Avenue, Ste 303, Orange Park, FL 32073 Ph: (904) 264-6800 | Larry L Mattingly, DO 2233 Park Avenue, Ste 303, Orange Park, FL 32073 Ph: (904) 264-6800 |
News Archive
A national clinical trial testing the efficacy of a novel brain tumor vaccine has begun at Wake Forest Baptist Medical Center, the only facility in the Southeast to participate.
Gloucester Pharmaceuticals announced today the presentation of positive data from an analysis of ISTODAX® (romidepsin) in a subset of patients from Gloucester's registration study in cutaneous T-cell lymphoma (CTCL) at the 51st American Society of Hematology (ASH) Annual Meeting being held in New Orleans, LA.
Ruthigen Inc., a biopharmaceutical company focused on pioneering new therapies to improve patient outcomes and reduce healthcare costs associated with infections related to post-operative invasive procedures, announces the initiation of a Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
In the course of a study conducted throughout Germany, medical professionals have compared different treatment methods for Neuromyelitis optica, an inflammatory disease of the central nervous system. It turned out that the best results were not achieved with conventional steroid therapy.
Researchers from the University of Auckland, New Zealand, have discovered that a potent new drug restores hearing after noise-induced hearing loss in rats. The landmark discovery found that injection of an agent called 'ADAC', activates adenosine receptors in cochlear tissues, resulting in recovery of hearing function. The finding paves the way for effective non-surgical therapies to restore hearing loss after noise-induced injury. Dr. Srdjan Vlajkovic and his team's work1 is published in a special edition of Springer's journal Purinergic Signalling, focusing on the inner ear.
› Verified 8 days ago
Payal Paresh Patel Shooliz, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2300 Park Ave Ste 102, Orange Park, FL 32073 Phone: 904-215-2510 Fax: 904-215-1515 | |
Mark Anthony Stawara, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2035 Professional Ctr Dr, Suite C, Orange Park, FL 32073 Phone: 904-272-0384 Fax: 904-272-6748 | |
Eugene H Mccoskey, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1893 Kingsley Ave, Suite C, Orange Park, FL 32073 Phone: 904-276-2044 Fax: 904-276-2106 | |
Dr. Nadeem Maalouli, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2140 Kingsley Ave, Orange Park, FL 32073 Phone: 904-213-0600 Fax: 904-213-0303 | |
Omer Ismaeel, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2140 Kingsley Ave Ste 1, Orange Park, FL 32073 Phone: 904-368-6809 | |
Shradha Pokharel, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2021 Kingsley Ave, Suite 101, Orange Park, FL 32073 Phone: 904-298-2113 Fax: 904-298-1922 | |
Charles Edward Phillips, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2035 Professional Ctr Dr, Ste C, Orange Park, FL 32073 Phone: 904-272-0384 Fax: 904-272-6748 |